Pharmaceuticals

Humira Drug Industry Anticipated to Expand at 7.8% CAGR During the Forecast Period

November 9, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Humira Drug Market By 2029?

The humira drug market size has demonstrated strong growth in recent years. It is projected to expand from $9.74 billion in 2024 to $10.33 billion in 2025, at a compound annual growth rate (CAGR) of 6.0%. The historical growth can be attributed to the introduction of biologics, advancements in biotechnology, patient demand for effective treatments, and physician adoption and prescribing patterns.

The humira drug market is anticipated to show considerable expansion over the coming years. Its valuation is projected to reach $13.93 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is primarily driven by factors such as the entry of biosimilars into the market, evolving healthcare policies, a strong emphasis on cost-effectiveness, significant investments in research and development, and the emergence of precision medicine and personalized treatments. Noteworthy trends expected in this period include the generation of real-world evidence, an increase in its use among pediatric populations, a shift towards self-administered medications, the implementation of value-based pricing models, and the ongoing development of targeted therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11934&type=smp

Which Industry Drivers Are Expected To Accelerate The Humira Drug Market From 2025 To 2029?

The Humira drug market is projected to expand due to an increasing incidence of autoimmune disease. Autoimmune conditions are characterized by the body’s immune system mistakenly attacking and damaging its own healthy tissues and cells. Humira is administered to manage the pain and inflammation associated with a range of autoimmune disorders, consequently, a higher incidence of these diseases will lead to increased demand for the drug. For example, data from March 2024 by the National Health Council, a US non-profit organization, indicates that approximately 50 million Americans are affected by autoimmune diseases. Nevertheless, the actual number is likely higher due to the inherent difficulties in diagnosing these conditions. Furthermore, autoimmunity is nearing epidemic levels, with certain research indicating an annual growth rate of 3-12%. Thus, the growing prevalence of autoimmune disease will be a key driver for the HUMIRA drug market.

What Are The Emerging Segments Gaining Attention In The Humira Drug Market?

The humira drug market covered in this report is segmented –

1) By Type: Humira Syringe, Humira Pen

2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s Disease, Other Applications

3) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Humira Syringe: Pre-Filled Syringe, Disposable Syringe

2) By Humira Pen: Auto-Injector Pen, Pre-Filled Injection Pen

What Trends Are Redefining The Humira Drug Market Dynamics?

Product innovation stands out as a significant trend within the humira drug market. Leading firms operating in the humira drug market are actively engaged in the creation of novel biologics and biosimilars, aiming to uphold their competitive standing. An example of this is Sandoz, a pharmaceutical company based in Switzerland, which launched Biosimilar Hyrimoz (adalimumab) in April 2023. This product is a citrate-free high-concentration formulation (HCF) that received approval from the European Commission. This adalimumab citrate-free HCF (100 mg/mL) formulation offers a 50 % decrease in injection volume and reduces the frequency of injections for individuals choosing dosages of 80 mg/mL or above. Its application extends to numerous conditions, including rheumatic diseases, Crohn’s disease, and other ailments, providing a more comfortable patient experience.

Who Are The Top Performing Companies In The Humira Drug Market In Recent Years?

Major companies operating in the humira drug market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/humira-drug-global-market-report

What Regional Growth Trends Are Shaping The Humira Drug Market Outlook?

North America was the largest region in the humira drug market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Humira Drug Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11934&type=smp

Browse Through More Reports Similar to the Global Humira Drug Market 2025, By The Business Research Company

Data Protection As A Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/data-protection-as-a-service-global-market-report

Cloud Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report

Application Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795